Fluconazole

This classification denotes an antifungal agent with the molecular formula C13H12F2N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8VZV102JFY, chemically known as 2,4-difluoro-alpha,alpha-bis(1h-1,2,4-triazol-1-ylmethyl)benzyl alcohol but generally known as fluconazole, which bears US NIH Compound Identifier 3365. European Medicines Agency schedules Fluconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07674MIG. The term FLUCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules fluconazole in its Anatomical Therapeutic Chemical (ATC) Classification. FLUCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluconazole under HS 29339990 and SITC 51577. As of Q4 2014, FLUCONAZOLE remains the US FDA Preferred Term for this commodity. Fluconazole bears US NLM identifiers UMLS ID C0016277 and NCI Concept Code C500. SMILES: FC1C(C(O)(CN2NCNC2)CN2NCNC2)CCC(F)C1.